Articles From: Ithaca Energy Inc.: 2014 Second Quarter & Half Year Results to Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137074&ProfileId=051205&sourceType=1 CALGARY, AB --
Sign-up for Ithaca Energy Inc.: 2014 Second Quarter & Half Year Results investment picks
ORLANDO, Fla.
Sign-up for Darden Announces Final Tender Results for Cash Tender Offer investment picks
Aureus Mining Inc. - Ebola in Liberia - Update Canada NewsWire TSX: AUE AIM: AUE TORONTO , Aug.
Sign-up for Aureus Mining Inc. - Ebola in Liberia - Update investment picks
WALLA WALLA, Wash.
Sign-up for Banner Corporation to Acquire Siuslaw Financial Group, Inc. investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961470001&sourceType=1 http://www.ccnmatthews.com/logos/20110815-freeholdroyalites.jpg CALGARY, ALBERTA --
Sign-up for Freehold Royalties Ltd. Announces 2014 Second Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961693001&sourceType=1 http://www.ccnmatthews.com/logos/20110603-200mel.jpg EDMONTON, ALBERTA --
Sign-up for Melcor Reports Second Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961627001&sourceType=1 http://www.ccnmatthews.com/logos/20090918-tera200.jpg TORONTO, ONTARIO --
Sign-up for TeraGo Reports Second Quarter 2014 Results investment picks
TYLER, Texas, Aug.
Sign-up for Southside Bancshares, Inc. Declares Cash Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961153001&sourceType=1 http://media3.marketwire.com/logos/20130909-909stn.jpg EDMONTON, ALBERTA and NEW YORK, NEW YORK --
Sign-up for Stantec reports solid second quarter 2014 results and dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961126001&sourceType=1 http://www.ccnmatthews.com/logos/20070727-tel0727.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for TELUS Reports Strong Results for Second Quarter 2014 investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported financial results for second quarter 2014 and provided an update on the Company’s business highlights.
Sign-up for Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business and Product Development Update investment picks
Safety Insurance Group, Inc. (NASDAQ:SAFT) today reported second quarter 2014 results.
Sign-up for Safety Announces Second Quarter 2014 Results and Raises Third Quarter 2014 Dividend investment picks
Board Recommends Darden Shareholders Vote "FOR ALL" of Darden's Eight Highly Qualified, Independent Director Nominees on BLUE Proxy Card Today ORLANDO, Fla.
Sign-up for Darden Files Definitive Proxy Materials And Two Investor Presentations In Connection With 2014 Annual Meeting investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) , a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, announced today that it has received a $125 million financing commitment from Deerfield Management Company L.P. (“Deerfield”), a current Aerie shareholder.
Sign-up for Aerie Announces $125 Million Convertible Notes investment picks
WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Corporation Announces Final Results of Tender Offers investment picks
Reviews Darden's New Slate of Independent Director Nominees and Highlights Risks Associated With the Full Board Turnover that Starboard Is Seeking ORLANDO, Fla.
Sign-up for Darden Issues Open Letter To Shareholders investment picks
http://media.marketwire.com/attachments/201408/271035_hnr.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141831&ProfileId=051205&sourceType=1 KANSAS CITY, MO --
Sign-up for H&R Block Announces Fiscal 2015 First Quarter Results investment picks
Company expands its Irvine location to accommodate the demand for proprietary mobile platform IRVINE, Calif.
Sign-up for Ubiquity, Inc. Expands Operations to Address Rapidly Growing Development Efforts for the Launch of Sprocket investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that on August 29, dosing commenced of the first patients enrolled in the Company’s Phase 3 registration trial in Canada of Rhopressa TM , a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
Sign-up for Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma investment picks
Under Reconstituted Board, Eight of Darden's 12 Independent Directors Would be New to the Board This Year Darden Board Would Include Four New Independent Nominees Unaffiliated with the Company or Starboard, Four Incumbent Independent Nominees and Four Starboard Nominees New Slate Provides Benefits of Fresh Perspectives and Continuity While Avoiding the Risks Associated with the Full Board Turnover and Control that Starboard Is Seeking New Darden Nominees Strengthen Company Slate with Additional International Restaurant, Franchise, Consumer, Real Estate and Operations Expertise to Support Development, Oversight and Execution of Operating and Brand Initiatives ORLANDO, Fla.
Sign-up for Darden Announces New Director Nominees For 2014 Annual Meeting Of Shareholders investment picks
Anticipated Results Also Show Improved Guest Satisfaction, Sales and Traffic Trends at Olive Garden as a Result of Brand Renaissance Plan ORLANDO, Fla.
Sign-up for Darden Announces Expected Fiscal First Quarter Results That Reflect Continued Progress On Operating Priorities And Affirms Earnings Outlook For Fiscal 2015 investment picks
RVX-208 Leads to a 77% Relative Risk Reduction of Major Adverse Cardiovascular Events (MACE) in Patients with Diabetes Mellitus Canada NewsWire Presented in 'State of the Art and Featured Research Session' at the 2014 European Society of Cardiology Congress TSX Exchange Symbol: RVX BARCELONA, Spain and CALGARY, AB , Sept.
Sign-up for RVX-208 Leads to a 77% Relative Risk Reduction of Major Adverse Cardiovascular Events (MACE) in Patients with Diabetes Mellitus investment picks
Presented in 'State of the Art and Featured Research Session' at the 2014 European Society of Cardiology Congress TSX Exchange Symbol: RVX BARCELONA, Spain and CALGARY, AB , Sept.
Sign-up for RVX-208 Leads to a 77% Relative Risk Reduction of Major Adverse Cardiovascular Events (MACE) in Patients with Diabetes Mellitus investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0955040001&sourceType=1 http://www.ccnmatthews.com/logos/20110601-enerflex.jpg CALGARY, ALBERTA --
Sign-up for Enerflex Completes Previously Announced International Contract Compression, Processing and After-Market Services Acquisition and Increases Credit Facilities investment picks
The Manitowoc Company, Inc. (NYSE: MTW) today acknowledged that Relational Investors LLC has filed a Schedule 13D with the Securities and Exchange Commission reporting that it has acquired beneficial ownership of 8.52% of the company's common stock.
Sign-up for The Manitowoc Company Highlights Commitment to Delivering Shareholder Value through Execution of Strategic Imperatives investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G017599-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/6/26/11G017599/20130207-eca_200-473944305185.jpg CALGARY, AB--(Marketwired - June 27, 2014) - Encana Corporation (TSX: ECA) (NYSE: ECA) Encana has reached an agreement with Calgary, Alberta-based Jupiter Resources to sell its Bighorn assets for approximately US$1.8 billion (C$2.0 billion). "This transaction advances our strategy by unlocking value from our portfolio as we focus on developing our core growth plays and extracting additional value from our base assets," says Doug Suttles, Encana President & CEO.
Sign-up for Encana Reaches Agreement to Sell Bighorn Assets to Jupiter Resources for Approximately US$1.8 Billion investment picks
Dr. Reddy’s Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2014 was filed with the United States Securities and Exchange Commission on June 26, 2014.
Sign-up for Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Ithaca Energy Inc.: 2014 Second Quarter & Half Year Results to Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices